vs
MEDALLION FINANCIAL CORP（MFIN）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
MEDALLION FINANCIAL CORP的季度营收约是RIGEL PHARMACEUTICALS INC的1.0倍（$70.6M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 17.3%，领先366.7%），MEDALLION FINANCIAL CORP同比增速更快（25.4% vs 21.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 15.0%）
Mahindra & Mahindra金融服务有限公司（MMFSL）是一家印度农村非银行金融公司，总部位于孟买。该公司是印度头部拖拉机融资机构之一，在印度全国拥有超过一千家分支机构
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
MFIN vs RIGL — 直观对比
营收规模更大
MFIN
是对方的1.0倍
$69.8M
营收增速更快
MFIN
高出4.2%
21.2%
净利率更高
RIGL
高出366.7%
17.3%
两年增速更快
RIGL
近两年复合增速
15.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $70.6M | $69.8M |
| 净利润 | $12.2M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 29.3% | 33.2% |
| 净利率 | 17.3% | 384.0% |
| 营收同比 | 25.4% | 21.2% |
| 净利润同比 | 20.3% | 1769.2% |
| 每股收益（稀释后） | $0.50 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MFINRIGL
| Q4 25 | $70.6M | $69.8M | ||
| Q3 25 | $58.7M | $69.5M | ||
| Q2 25 | $62.6M | $101.7M | ||
| Q1 25 | $63.0M | $53.3M | ||
| Q4 24 | $56.3M | $57.6M | ||
| Q3 24 | $53.3M | $55.3M | ||
| Q2 24 | $51.0M | $36.8M | ||
| Q1 24 | $53.3M | $29.5M |
净利润MFINRIGL
| Q4 25 | $12.2M | $268.1M | ||
| Q3 25 | $7.8M | $27.9M | ||
| Q2 25 | $11.1M | $59.6M | ||
| Q1 25 | $12.0M | $11.4M | ||
| Q4 24 | $10.1M | $14.3M | ||
| Q3 24 | $8.6M | $12.4M | ||
| Q2 24 | $7.1M | $-1.0M | ||
| Q1 24 | $10.0M | $-8.2M |
毛利率MFINRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率MFINRIGL
| Q4 25 | 29.3% | 33.2% | ||
| Q3 25 | 33.2% | 40.9% | ||
| Q2 25 | 31.1% | 60.1% | ||
| Q1 25 | 32.1% | 23.9% | ||
| Q4 24 | 32.8% | 28.9% | ||
| Q3 24 | 26.6% | 25.4% | ||
| Q2 24 | 24.3% | 1.2% | ||
| Q1 24 | 33.6% | -23.6% |
净利率MFINRIGL
| Q4 25 | 17.3% | 384.0% | ||
| Q3 25 | 13.2% | 40.2% | ||
| Q2 25 | 17.7% | 58.6% | ||
| Q1 25 | 19.1% | 21.5% | ||
| Q4 24 | 18.0% | 24.9% | ||
| Q3 24 | 16.1% | 22.5% | ||
| Q2 24 | 13.9% | -2.8% | ||
| Q1 24 | 18.8% | -27.9% |
每股收益（稀释后）MFINRIGL
| Q4 25 | $0.50 | $14.11 | ||
| Q3 25 | $0.32 | $1.46 | ||
| Q2 25 | $0.46 | $3.28 | ||
| Q1 25 | $0.50 | $0.63 | ||
| Q4 24 | $0.43 | $0.82 | ||
| Q3 24 | $0.37 | $0.70 | ||
| Q2 24 | $0.30 | $-0.06 | ||
| Q1 24 | $0.42 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $136.3M | $155.0M |
| 总债务越低越好 | $216.0M | $52.5M |
| 股东权益账面价值 | $408.6M | $391.5M |
| 总资产 | $3.0B | $513.6M |
| 负债/权益比越低杠杆越低 | 0.53× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资MFINRIGL
| Q4 25 | $136.3M | $155.0M | ||
| Q3 25 | $72.5M | $137.1M | ||
| Q2 25 | $110.4M | $108.4M | ||
| Q1 25 | $131.5M | $77.1M | ||
| Q4 24 | $98.2M | $77.3M | ||
| Q3 24 | $120.6M | $61.1M | ||
| Q2 24 | $87.7M | $49.1M | ||
| Q1 24 | $54.8M | $49.5M |
总债务MFINRIGL
| Q4 25 | $216.0M | $52.5M | ||
| Q3 25 | $215.7M | $60.0M | ||
| Q2 25 | $199.9M | $60.0M | ||
| Q1 25 | $199.7M | $60.0M | ||
| Q4 24 | $232.2M | $60.0M | ||
| Q3 24 | $232.0M | $60.0M | ||
| Q2 24 | $230.8M | $60.0M | ||
| Q1 24 | $225.6M | $60.0M |
股东权益MFINRIGL
| Q4 25 | $408.6M | $391.5M | ||
| Q3 25 | $397.4M | $117.6M | ||
| Q2 25 | $389.9M | $81.9M | ||
| Q1 25 | $380.2M | $18.6M | ||
| Q4 24 | $370.2M | $3.3M | ||
| Q3 24 | $362.4M | $-14.6M | ||
| Q2 24 | $354.0M | $-29.9M | ||
| Q1 24 | $349.0M | $-31.7M |
总资产MFINRIGL
| Q4 25 | $3.0B | $513.6M | ||
| Q3 25 | $2.9B | $242.5M | ||
| Q2 25 | $2.9B | $206.7M | ||
| Q1 25 | $2.8B | $176.0M | ||
| Q4 24 | $2.9B | $164.0M | ||
| Q3 24 | $2.9B | $139.4M | ||
| Q2 24 | $2.8B | $128.4M | ||
| Q1 24 | $2.6B | $126.5M |
负债/权益比MFINRIGL
| Q4 25 | 0.53× | 0.13× | ||
| Q3 25 | 0.54× | 0.51× | ||
| Q2 25 | 0.51× | 0.73× | ||
| Q1 25 | 0.53× | 3.23× | ||
| Q4 24 | 0.63× | 18.25× | ||
| Q3 24 | 0.64× | — | ||
| Q2 24 | 0.65× | — | ||
| Q1 24 | 0.65× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $126.3M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 10.35× | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流MFINRIGL
| Q4 25 | $126.3M | $22.0M | ||
| Q3 25 | $67.0M | $24.0M | ||
| Q2 25 | $-10.7M | $30.5M | ||
| Q1 25 | $36.3M | $-893.0K | ||
| Q4 24 | $108.7M | $14.5M | ||
| Q3 24 | $24.6M | $21.7M | ||
| Q2 24 | $27.6M | $302.0K | ||
| Q1 24 | $32.3M | $-5.0M |
现金转化率MFINRIGL
| Q4 25 | 10.35× | 0.08× | ||
| Q3 25 | 8.63× | 0.86× | ||
| Q2 25 | -0.97× | 0.51× | ||
| Q1 25 | 3.02× | -0.08× | ||
| Q4 24 | 10.72× | 1.01× | ||
| Q3 24 | 2.86× | 1.75× | ||
| Q2 24 | 3.89× | — | ||
| Q1 24 | 3.22× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
